Tweet
Everyday Health interviewed me about my experience in Phase 2. Good read. - D
Stem Cell Transplants for MS: HALT-MS Trial Gears Up for Its Next Phase
One of the most prominent clinical trials of stem cell transplants for MS will enroll new participants in early 2018.
By Quinn Phillips
Medically Reviewed by Samuel Mackenzie, MD, PhD
A few years ago, Everyday Health reported on a clinical trial called HALT-MS. This ongoing study is one of several in recent years to investigate stem cell transplants for multiple sclerosis (MS), in which a person’s own stem cells are harvested before a course of chemotherapy is given to almost completely destroy the immune system, after which the stem cells are infused back into the body.
HALT-MS is one of the most prominent ongoing trials involving stem cell transplants for MS, and its researchers have their sights set on making transplantation a mainstream treatment for MS. But first, they need to directly compare transplantation with the best drug-based treatments currently available — which is exactly what phase 3 of the trial will do.
Whether you’re potentially interested in participating in future clinical trials, or just eager to learn about where*MS treatment may be headed, here’s an overview of what researchers hope to learn in the study’s next phase and what it may mean for participants.
http://www.everydayhealth.com/multip...halt-ms-trial/
Stem Cell Transplants for MS: HALT-MS Trial Gears Up for Its Next Phase
One of the most prominent clinical trials of stem cell transplants for MS will enroll new participants in early 2018.
By Quinn Phillips
Medically Reviewed by Samuel Mackenzie, MD, PhD
A few years ago, Everyday Health reported on a clinical trial called HALT-MS. This ongoing study is one of several in recent years to investigate stem cell transplants for multiple sclerosis (MS), in which a person’s own stem cells are harvested before a course of chemotherapy is given to almost completely destroy the immune system, after which the stem cells are infused back into the body.
HALT-MS is one of the most prominent ongoing trials involving stem cell transplants for MS, and its researchers have their sights set on making transplantation a mainstream treatment for MS. But first, they need to directly compare transplantation with the best drug-based treatments currently available — which is exactly what phase 3 of the trial will do.
Whether you’re potentially interested in participating in future clinical trials, or just eager to learn about where*MS treatment may be headed, here’s an overview of what researchers hope to learn in the study’s next phase and what it may mean for participants.
http://www.everydayhealth.com/multip...halt-ms-trial/
Comment